drugset / Trial / NCT00865228
Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the role of time of dosing on the lipid-lowering effects of lapaquistat acetate, once daily (QD) or twice daily (BID), in subjects with hypercholesterolemia.
Timeline
- Start
- 2007-07
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lapaquistat acetate | Small molecule | 50 mg | Oral |
| Subject | Lapaquistat acetate | Small molecule | 100 mg | Oral |